Stephen Schlachter's Contact Details

Stephen Schlachter's Company Details

Edgewise Therapeutics

Boulder, CO, US • 50 - 99 Employees
Biotech/Healthcare

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise's platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.